FAQ

Kerecis Skin Substitute Answers

Frequently Asked Questions

Kerecis is full-thickness fish skin that has a similar composition and structure that closely resembles human skin. It is minimally processed retaining it’s lipid composition and other natural skin elements that support wound management.

Other differentiating factors include:

  • Easy application, easy to handle
  • Evidence-based efficacy
  • 4 Randomized clinical trials
  • No cultural or religious barriers to clinician/patient acceptance
  • Room temperature storage and long shelf life
  • No known risk of viral disease transfer

Kerecis uses intact fish skin from Icelandic cod, which are caught in the pristine waters of North Iceland. The fish comes exclusively from stock that the Marine Stewardship Council has certified as sustainable.

No. Kerecis® Wound is shelf stable for three years and can be stored at room temperature.

The graft is hydrated with saline prior to application and is cut and placed designed to conform to the wound’s shape with minimal overlap, after which it is covered with a sterile secondary dressing.”

No. All scales have been removed as part of the gentle processing that retains the fish skin’s EPA.

Yes. Kerecis® Wound is covered for reimbursement by Medicare in every state.

KM-23-0279.1

Need more
information?

From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions.
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding field of cellular therapy.
Kerecis is part of Coloplast, the leading global supplier of intimate healthcare products.
KM-23-0279.1